Azitrobac

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azitrobac

What is Azitrobac?

Azitrobac is an antibacterial medication belonging to the macrolide class. It is primarily used to address various types of bacterial infections by interfering with the way bacteria produce the proteins necessary for their growth and multiplication. By inhibiting these processes, the medication helps the body's immune system to clear the infection.

Mechanism of Action

The active component in Azitrobac works by binding to the 50S subunit of the bacterial ribosome. This action blocks protein synthesis, which prevents the bacteria from replicating. Because it focuses specifically on bacterial structures, it does not typically affect human cells in the same manner. This mechanism classifies the drug as bacteriostatic, meaning it inhibits growth, though it can be bactericidal against certain organisms at higher concentrations.

Therapeutic Applications

Azitrobac is utilized across several clinical areas to manage infections caused by susceptible microorganisms. These include:

  • Respiratory Tract Infections: Management of conditions affecting the upper and lower respiratory systems, such as inflammation of the sinuses, throat, and lungs.
  • Skin and Soft Tissue Infections: Treatment of uncomplicated bacterial infections involving the skin layers.
  • Genitourinary Infections: Addressing specific sexually transmitted infections caused by certain bacteria.
  • Ear Infections: Use in cases of middle ear inflammation, particularly in pediatric populations.

Characteristics

Azitrobac is characterized by its long half-life, which allows for shorter treatment courses compared to many other antibiotics. It is known for its ability to achieve high concentrations within tissues, often remaining at therapeutic levels in the infected area for several days after the final dose has been administered.

Regulatory References

  1. MedlinePlus

What side effects are possible with Azitrobac?

Possible side effects and safety information

The safety profile of Azitrobac (Azithromycin) is based strictly on classifications documented in official government regulatory labels, defining observed adverse reactions by frequency and physiological system.

Adverse Reaction Categories

Adverse reactions are formally categorized based on incidence rates observed in clinical use and post-marketing surveillance:

  • Common Reactions: The most frequently documented effects, typically involving the Gastrointestinal System, include diarrhea, abdominal pain, nausea, vomiting, and headache.
  • Less Common/Rare Reactions: These span various systems and include sleep disorders, rash, vertigo, and a rare risk of liver dysfunction or cholestatic jaundice.

Serious Safety Characteristics

Regulatory documents emphasize specific, rare, but clinically serious adverse reactions that affect major organ systems:

System-Organ Class Serious Adverse Reaction Note on Severity
Cardiac Disorders QT interval prolongation, Torsades de Pointes Potential for fatal irregular heartbeat
Hepatobiliary Disorders Hepatic failure, Cholestatic jaundice Can be fatal and is a constraint
Immune/Skin System Stevens-Johnson Syndrome (SJS), DRESS Severe, potentially life-threatening skin reactions

Population-Specific Safety Notes

The official prescribing information includes specific safety considerations for certain groups. Older adults may face a higher risk for Torsades de Pointes. The use of Azithromycin in neonates is associated with a risk of Infantile Hypertrophic Pyloric Stenosis (IHPS). The medicine is restricted in patients with a history of hepatic dysfunction or known hypersensitivity to macrolides, as elimination primarily involves the liver.

Time-Related Patterns: Allergic symptoms associated with the medicine may reappear even after treatment has concluded. The risk of serious cardiovascular events may be greatest during the initial days of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes that an overdose of Azitrobac (Azithromycin) typically involves an exacerbation of documented side effects seen at normal therapeutic doses.

Documented Overdose Manifestations

Symptoms frequently documented in regulatory labeling are severe gastrointestinal disturbances, including nausea, vomiting, and diarrhea . There have also been reports of reversible loss of hearing associated with high systemic exposure.


Urgent Risks and Required Actions

The most critical documented risk is the potential for cardiotoxicity, specifically the prolongation of the QT interval on an electrocardiogram, which can lead to life-threatening cardiac arrhythmias such as Torsades de pointes (TdP). This risk is particularly noted for patients with pre-existing cardiovascular conditions.

Treatment for overdose is strictly symptomatic and supportive, as no specific antidote is known

. Regulators indicate that administration of medicinal charcoal may be required as part of the management procedure.

When to Contact Emergency Services

Immediate medical attention is required for any signs of serious cardiac effects. Regulatory guidelines mandate contacting emergency services (e.g., 911) if the affected person experiences collapse, a seizure, trouble breathing, or cannot be awakened. Urgent help must also be sought for symptoms like a fast, pounding, or irregular heartbeat, dizziness, or fainting.

Therapeutic Uses of Azitrobac

What Azitrobac Treats: Main Uses and Benefits

Azitrobac, containing the antibiotic Azithromycin, is commonly used to help manage conditions characterized by periods of heightened symptoms that are caused by susceptible bacteria. This medicine is applied across therapeutic domains involving distressing symptoms in the ears, lungs, sinuses, throat, skin, and reproductive organs.


The medication is commonly used across conditions marked by increased physiological stress, including acute respiratory infections like pneumonia and bronchitis exacerbations, as well as infections of the ear, sinuses, skin, and certain sexually transmitted infections (STIs) such as Chlamydia. This medicine helps address symptom clusters that may become intense or disruptive, including high fever, persistent cough, sore throat, ear pain, and localized discharge.

“It is considered relevant in clinical settings where acute manifestations interfere with function, and short-term symptomatic assistance is needed.”

When used in these scenarios, treatment contributes to easing the overall symptom load by addressing the bacterial nature of the condition, supporting a return to functional stability. Furthermore, it supports general well-being during symptomatic phases for immunocompromised patients who may be applied prophylaxis against infections like Mycobacterium avium complex (MAC).

Quick Fact: Support for Respiratory Symptoms
Azitrobac may assist with managing symptoms that interfere with daily functioning, such as cough and difficulty breathing, when they are linked to acute bacterial infections of the lungs.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Azitrobac eligibility is governed by official regulatory standards defining who may use the medicine, who must not, and under what conditions.

Absolute Non-Eligibility (Contraindications)

Azitrobac is contraindicated for patients with known hypersensitivity to Azithromycin or any other Macrolide/Ketolide antibiotic. It is also prohibited for individuals with a history of cholestatic jaundice or hepatic dysfunction associated with prior Azithromycin use. Use is generally not recommended in those with severe hepatic impairment.

Conditional Use (Caution Required)

The medicine requires caution in patients with specific pre-existing risk factors, including known or suspected QT interval prolongation, clinically significant bradycardia, or uncorrected hypokalemia/hypomagnesemia. Caution is also officially advised in cases of severe renal impairment (GFR less than 10 mL/min) and for patients with Myasthenia Gravis due to the potential for symptom exacerbation.

Age and Physiological Status

Safety and efficacy are not established for most indications in children under 6 months of age. For pregnancy, use is restricted and advised only if clearly needed after official risk assessment. Azithromycin is present in breast milk, requiring a decision to discontinue either nursing or the medicine, as documented in regulatory labels.

What should I know about interactions with other medicines?

Azitrobac (azithromycin) has a relatively low potential for drug interactions compared to other macrolide antibiotics, but important interactions can still occur. Always inform your healthcare provider about all prescription, over-the-counter (OTC) medicines, vitamins, and herbal supplements you are taking.

Potential Drug Interactions

Medicine Group or Product Example Medicines Potential Effect and Management
Antacids (containing aluminum or magnesium) Maalox, Mylanta Can reduce the absorption and effectiveness of Azitrobac. Separate the dose of Azitrobac by at least 2 hours before or after taking the antacid.
Anticoagulants (Blood Thinners) Warfarin May enhance the effect of the blood thinner, increasing the risk of bleeding. Close monitoring of blood clotting time (INR) is typically required.
Heart Rhythm Medicines Amiodarone, Sotalol Increases the risk of a serious irregular heart rhythm (QT prolongation). Concomitant use is generally not recommended.
Cholesterol-Lowering Medicines (Statins) Atorvastatin, Simvastatin May increase the risk of muscle damage (rhabdomyolysis). Close monitoring for muscle pain or weakness is important.
Digoxin Digoxin May increase Digoxin levels, leading to increased risk of toxicity. Monitoring of Digoxin levels is recommended.
Colchicine Colchicine May increase the risk of Colchicine-related side effects, such as gastrointestinal and muscle problems.
Ergot Alkaloids Ergotamine, Dihydroergotamine Concomitant use is generally avoided due to the potential for severe circulatory problems.

It is also advised to consult a healthcare professional regarding the use of any herbal remedies or supplements while taking Azitrobac, as their interactions are often not fully studied. Azitrobac generally does not interact with common pain relievers like ibuprofen or acetaminophen.

Mechanism of Action

Azitrobac, containing Azithromycin, works through dual mechanistic actions: a primary molecular inhibition of microbial growth and a secondary influence on host physiology.

The primary mechanism involves a highly selective action against bacteria that lack resistance mechanisms. The molecule functions as an inhibitor by binding to the 50S ribosomal subunit within the microbe, specifically targeting the 23S ribosomal RNA at the polypeptide exit tunnel. By mechanically blocking this tunnel, Azithromycin prevents the process of translocation and the necessary elongation of protein chains. The functional consequence of this binding event is the inhibition of microbial proliferation (bacteriostasis).

Additionally, the molecule exhibits an influence on host immune function. It accumulates at high concentrations inside phagocytic immune cells (e.g., macrophages), which act as carriers and concentrate the drug in host tissues. Azithromycin also interacts with host cells, influencing the release of certain pro-inflammatory mediators, thereby adjusting the pathway activity associated with specific biological responses.

Dosage and Administration Information

How Azitrobac is Used: Official Administration Guidelines

Azitrobac, containing Azithromycin, is administered either orally (via tablets, capsules, or suspensions) or intravenously (IV). The IV route is reserved for initial therapy in specific moderate-to-severe infections, followed by a transition to oral administration to complete a treatment course, often spanning 7 to 10 days overall.

Standard Dosing and Frequency

Usage is structured around fixed total doses delivered over short periods, typically on a once-daily schedule. Common adult oral regimens include a single dose of 1 g or 2 g, or multi-day courses such as 500 mg daily for 3 days, or a 5-day course starting with 500 mg on the first day, followed by 250 mg on the remaining four days. Certain prophylactic uses may follow an once-weekly schedule.

Administration Context and Special Conditions

Administration in relation to meals is dependent on the specific dosage form. The Tablets and Standard Oral Suspension may be taken with or without food. Conversely, Capsules and the Extended-Release Suspension must be taken on an empty stomach (at least 1 hour before or 2 hours after a meal).

For the intravenous formulation, the powder must be reconstituted and diluted before being administered as a slow infusion over 1 to 3 hours, never as a bolus or intramuscular injection. Regarding a missed oral dose, official guidance states that if more than 12 hours have elapsed, the dose should be skipped and the regular schedule resumed. For older adults, the standard adult dosing regimen is generally applied, and no dose adjustment is required for patients with mild-to-moderate renal or hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Azitrobac

This section describes the types of clinical studies that have been conducted on Azitrobac (Azithromycin) for its studied uses, focusing on what researchers monitored and where uncertainty remains. It is intended to provide a neutral overview of the evidence landscape.


Evidence for Acute Respiratory, Ear, and Sinus Infections

Research was studied for short-term treatment of acute bacterial infections. These studies primarily use short-term randomized controlled trials (RCTs). Researchers in these settings monitored outcomes related to physical discomfort and systemic imbalance, such as fever, cough, and ear pain. The key measures observed were outcomes related to clinical failure or improvement in the observed populations, typically around 10 to 14 days.

Findings from various pooled analyses often described clinical failure rates observed across different study arms. Studies focusing on specific conditions like acute bronchitis described the specific patterns observed for the studied intervention. The primary uncertainty relates to the consistency of findings. Pooled data often display significant variability across studies, meaning the results were mixed, and certainty remains low when trying to draw a broad conclusion across all types of acute respiratory infections.


Evidence for Long-Term Prevention and Prophylaxis

Azitrobac was evaluated in long-term use in patients with conditions characterized by fluctuating or episodic manifestations, specifically for research exploring whether it could influence the frequency of acute episodes in chronic lung diseases (CLD) like COPD. These studies used long-term RCTs, sometimes lasting one to two years, where researchers monitored the frequency of episodes where symptoms become more noticeable (exacerbations).

These long-term studies reported patterns observed in the studies regarding the frequency of acute exacerbations across the monitored groups. However, research also highlights that long-term use was associated with observed changes in the microbiological resistance patterns of bacteria isolated from the respiratory tract. Long-term effects are not fully established beyond the observation period of the primary trials, and the durability of the observed response over many years is not well characterized. Data are still emerging regarding the clinical implications of the observed resistance patterns.

Key Studies & References

  1. Zithromax (Azithromycin) Prescribing Information (Pivotal Clinical Trials and Regulatory Basis)
  2. Azithromycin for Prevention of Exacerbations of COPD (Landmark Long-Term RCT)
  3. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (MAC Prophylaxis)

Frequently Asked Questions (FAQ)

Common questions about Azitrobac (FAQ)

Q: Do you have to take Azitrobac with food?

A: Whether Azitrobac should be taken with food depends entirely on the specific dosage form prescribed. Official administration guidelines state that tablets and the standard oral suspension can be taken either with or without a meal. However, if the prescription is for the capsules or the extended-release oral suspension, these should be taken on an empty stomach, typically prescribed as one hour before or two hours after eating.

Q: How long does Azitrobac stay in your system after the last dose?

A: Azitrobac, which contains Azithromycin, is known for its relatively long presence in the body. Pharmacokinetic studies indicate the drug has an extended half-life, meaning it is eliminated slowly, with the elimination process typically lasting between two and four days after the final dose. This prolonged effect is due to the drug being highly concentrated and slowly released from body tissues.

Q: Is it common to have diarrhea while taking Azitrobac?

A: Yes, diarrhea or loose stools are among the most frequently reported side effects associated with Azitrobac use. Regulatory documents categorize diarrhea as a common adverse effect reported in clinical trials. Severe or persistent symptoms should always be discussed with a healthcare professional.

Q: Can Azitrobac cause stomach pain, and is that normal?

A: Stomach pain, also known as abdominal pain, is listed in official product information as a common adverse reaction. It is one of the more frequently occurring gastrointestinal side effects, along with nausea and vomiting. If the pain is severe or persists, contacting a healthcare professional is generally recommended.

Q: Does Azitrobac work for chest infections?

A: Yes, Azitrobac is indicated for the treatment of certain lower respiratory tract infections, which include what people commonly refer to as chest infections. Specifically, it is approved for conditions like community-acquired pneumonia and acute exacerbations of chronic bronchitis.

Q: What's the difference between Azitrobac and amoxicillin?

A: The difference lies in their mechanism of action, or how they work to fight bacteria. Azithromycin (Azitrobac) is an Azalide antibiotic that blocks bacterial protein production. Amoxicillin, by contrast, belongs to the Penicillin class and works by preventing the bacteria from building cell walls.

Q: Can men take Azitrobac for common STIs?

A: Official therapeutic indications state that Azithromycin is used to treat certain uncomplicated sexually transmitted infections. Specifically, it is indicated for the treatment of uncomplicated urethritis and cervicitis caused by the bacterium Chlamydia trachomatis.

Q: Can Azitrobac be used to treat a tooth infection?

A: Official therapeutic indications do not explicitly list tooth or dental infections. The medicine is primarily approved for respiratory tract, skin, and soft tissue infections. The decision for its use in dental issues is made by a healthcare professional based on the patient’s specific clinical needs.

Q: Is Azitrobac effective for viral infections?

A: No, Azitrobac is an antibiotic and is effective only against susceptible bacteria. Official product information confirms that it is not effective for treating infections caused by viruses, such as the common cold or the flu.

Q: Can Azitrobac affect your sleep?

A: Uncommon side effects that have been reported with Azitrobac use include sleep disorders, such as insomnia. Other central nervous system effects like dizziness and headache are also reported, which could potentially impact alertness. Significant or bothersome sleep changes are conditions that should be discussed with a healthcare provider.

Q: Are there any common foods to avoid while taking Azitrobac?

A: Official drug information does not list any specific common foods that must be avoided while taking Azitrobac. The main food-related restriction concerns the timing of administration for certain dosage forms, such as taking the capsule form on an empty stomach.

Q: Is it okay to drink coffee while on Azitrobac?

A: Yes, official drug interaction information does not report any known interaction between azithromycin (the active ingredient in Azitrobac) and caffeine or coffee.

Q: Can Azitrobac cause a metallic taste in your mouth?

A: An altered sense of taste, medically known as dysgeusia, has been reported as a side effect. This change in taste can sometimes be described by patients as a metallic or unusual taste. If this change in taste becomes severe or distracting, it is appropriate to consult a healthcare professional.

Q: Does Azitrobac make you more sensitive to the sun?

A: Photosensitivity reactions (an increased sensitivity to sunlight) have been reported rarely with macrolide antibiotics, including Azithromycin, during post-marketing surveillance. Following standard sun protection practices is generally considered prudent when taking this medication class.

Q: Is Azitrobac used to treat ear infections in adults?

A: Yes, Azitrobac is indicated for the treatment of acute bacterial otitis media (ear infection). This indication applies to both adults and children.

Q: Can Azitrobac cause thrush or yeast infections?

A: Yes, yeast infections of the mouth (thrush) and vagina are listed as an uncommon adverse effect in the drug's safety information. This can happen with many antibiotics as they may disrupt the natural balance of microorganisms in the body.

Q: What if I vomit shortly after taking Azitrobac?

A: If vomiting occurs shortly after taking Azitrobac, particularly within an hour of the dose, official guidance advises consulting a healthcare provider for clarification on whether a repeat dose is necessary. If more than 12 hours have passed since the scheduled dose, the dose is typically skipped, and the regular schedule is resumed.

Q: Is it normal for a rash to appear while on Azitrobac?

A: Rash is listed as an uncommon adverse effect. While most rashes are minor, Azithromycin is associated with rare, but potentially serious and life-threatening skin reactions. Due to the potential for serious reactions, any rash should be promptly evaluated by a healthcare professional.

Q: Is Azitrobac effective against H. pylori?

A: Azithromycin is not considered a primary, first-line treatment for H. pylori infection (the bacterium that can cause stomach ulcers). However, it has been used in specific regions or as part of combination therapy when primary therapies are unsuitable.

Q: Can Azitrobac affect birth control pills?

A: Regulatory information indicates that some antibiotics, including Azithromycin, may potentially reduce the effectiveness of oral contraceptives, specifically those containing ethinyl estradiol. Patients are generally advised to consult with a healthcare provider to discuss the possible need for alternative or additional contraceptive methods during treatment.

Q: Can Azitrobac interact with medications for heartburn or acid reflux?

A: Yes, it can interact with certain medications used for heartburn. Antacids containing aluminum or magnesium can reduce the absorption of Azitrobac, which necessitates separating the dose by at least two hours. Additionally, it may interact with H2 blockers, which could carry a risk of an irregular heart rhythm.

Q: How does Azitrobac compare to other macrolide antibiotics?

A: Azitrobac belongs to the Azalide subclass of macrolides, which gives it certain pharmacological characteristics compared to older macrolides like erythromycin. This classification is due to its unique chemical structure, which is noted for contributing to a longer half-life and greater concentration within body tissues.

Q: Does Azitrobac have an anti-inflammatory effect?

A: Studies suggest that Azithromycin does possess immunomodulatory and anti-inflammatory properties in addition to its primary antibacterial function. It has been shown to influence the release of pro-inflammatory mediators, an effect that has been explored in chronic respiratory conditions.

Q: Can Azitrobac cause headaches?

A: Yes, headache is listed in official product information as a common adverse reaction associated with taking Azitrobac.

Q: Does Azitrobac make you drowsy?

A: While drowsiness (somnolence) is listed as a less common side effect, adverse effects like dizziness and vertigo are also reported in regulatory documents. The potential for these side effects means a temporary reduction in alertness is possible.

Q: Can Azitrobac treat traveler's diarrhea?

A: Azithromycin is a recognized treatment option for certain causes of bacterial traveler's diarrhea. This use is often recommended by health organizations, particularly in areas where high levels of resistance to other common antibiotics are present.

Q: How quickly should I expect to feel better after starting Azitrobac?

A: While the response varies per individual and infection, patient information suggests that for most common bacterial infections, an individual may begin to feel better within a few days of starting Azitrobac. It remains important to complete the full course as prescribed, even if symptoms begin to improve quickly.

Q: Is Azitrobac effective for sore throats caused by strep?

A: Azithromycin is indicated for pharyngitis/tonsillitis (sore throat), but for infections caused by Streptococci (strep throat), it is typically reserved as a second-line therapy. The specific decision for its use is based on a healthcare professional's assessment of the infection.

Q: Is it safe to drive after taking Azitrobac?

A: Official product information states there is no specific evidence to suggest that Azithromycin impairs your ability to drive or operate machinery. However, if side effects like dizziness, vertigo, or visual disturbances occur, it is prudent to use caution and avoid driving or operating machinery until these effects are resolved.

How should Azitrobac be stored and disposed of?

Azithromycin Storage and Disposal

The required storage and disposal of azithromycin (Azitrobac) are strictly defined by regulatory guidelines to ensure stability.


Storage Conditions and Stability

Dosage Form Required Storage Condition
Oral Tablets Store at 15 C to 30 C (59 F to 86 F), protected from moisture and light.
Dry Powder Store below 30 C (86 F) in the original, tightly closed container.
Constituted Liquid Store between 5 C to 30 C (41 F to 86 F) and must not be frozen.

Handling and Disposal

The reconstituted liquid suspension is stable for 10 days and any remaining liquid must be discarded after the full course of therapy. All forms must be stored out of the reach and sight of children. Unused or expired medication should be disposed of in the household trash after being mixed with an undesirable substance like dirt or used coffee grounds, following official guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azitrobac found in:

A-Z Index: